JP2010035555A - Biosensor utilizing dna as element - Google Patents

Abstract

<P>PROBLEM TO BE SOLVED: To provide a method which can detect and/or quantify an analyte in a sample by utilizing a sensor protein that can bind to the analyte specifically and a nucleic acid that can be recognized by the sensor protein specifically, and which is excellent in terms of cost, operability and rapidity. <P>SOLUTION: An ArsR protein which is a sensor protein capable of binding to arsenic, and a green fluorescent protein (GFP) are fused together to produce ArsR-GFP. It is confirmed that the fusion protein can bind to a specific recognition sequence (P<SB>ars</SB>-DNA), and it is also confirmed that the binding between the fusion protein and P<SB>ars</SB>-DNA can be inhibited by arsenious acid. Next, a plate having P<SB>ars</SB>-DNA immobilized thereon is prepared. It is found that the quantity of ArsR-GFP bound to the P<SB>ars</SB>-DNA-immobilized plate is decreased in an arsenious acid concentration-dependent manner. <P>COPYRIGHT: (C)2010,JPO&INPIT

Description

  The present invention relates to a method for detecting and / or quantifying an analyte in a test sample by using a sensor protein that specifically binds to the analyte and a nucleic acid specifically recognized by the sensor protein. .

  Currently, contamination of soil, groundwater, surface water, and the like by harmful metal compounds such as lead, cadmium, and arsenic has been reported, which is a major problem in various parts of the world. Methods used to analyze toxic metal contamination in the environment include flame atomic absorption spectroscopy (AAS), flameless atomic absorption spectroscopy (FLAA), inductively coupled plasma emission spectroscopy (ICP-AES), and inductively coupled plasma mass. Analysis methods (ICP-MS) and the like are known. However, these instrumental analysis methods require sample pretreatment in order to perform analysis, and cannot cope with rapid analysis on site, and have a disadvantage of high running costs.

  There is an urgent need to develop a simple detection method for toxic metals that compensates for the shortcomings of instrumental analysis. A biosensor that uses a test molecule such as an enzyme, antibody, or receptor derived from a living organism that identifies a detection target substance as a sensor element is also attracting attention as one of such simple detection methods. In biosensors, the detection reaction is based on biochemical reaction and binding specificity, so high-sensitivity measurement is possible, measurement and detection is quick and simple, the running cost is low, and the sensor itself is small and excellent in portability. There are advantages. In addition, the use of biochemical reactions such as enzyme reactions, antigen-antibody reactions, and ligand binding to receptors enables analysis with high specificity to specific substances. It is possible to reduce the size.

  While various biosensors are being researched, biosensors using microbial cells are easy to culture and easy to manipulate, so a wide selection of detection target substances and reporter genes is possible, and expansion of applications is expected. Has been. A recombinant microbial biosensor consists of three elements: a host cell, an inducible promoter that promotes transcription to a downstream gene in response to a specific substance, and a reporter gene downstream of the promoter, and optionally detects the signal emitted by the reporter A system combining devices is used. In this system, luciferases derived from bacteria and fireflies (see Non-patent Documents 1 to 3), GFP derived from Aequorea jellyfish (see Non-Patent Documents 2 and 4), LacZ derived from E. coli (non-patent documents) Patent Documents 2 and 5).

  The present inventors have already developed an arsenic-responsive biosensor using the carotenoid synthase CrtA as a reporter and the marine photosynthetic bacterium Rhodovulum sulfidophilum as a host (Non-patent Document 6). Rhodobram sulphidophilum has a spheroidene pathway, a kind of carotenoid synthesis system, and originally accumulates the final product spheroidenone and is a red bacterium. Since this sensor uses a crtA-deficient strain obtained by destroying crtA encoding spheroidene monooxygenase (CrtA) that catalyzes the final step of the spheroidene pathway, it accumulates the spheroidene precursor of spheroidene. It is yellow. Therefore, CrtA activity is restored in the presence of arsenic by introducing a plasmid containing crtA as a reporter gene and incorporating an arsenic-inducible promoter upstream thereof into Rhodobram sulphidophilum, so that the color changes from yellow to red. Color change occurs. The presence of arsenic can be determined using such a change in color tone as an index.

  Furthermore, the inventors of the present invention have reported that Rhodopseudomonas pultris, which is a freshwater red bacterium that can be cultured under anaerobic conditions, and phytoene-to-lycopene phytoene desaturase (CrtI) in the spiroloxanthin pathway possessed by Rhodopseudomonas pultris. ), A plasmid incorporating a reporter gene crtI downstream of an arsenic-inducible operator / promoter region derived from E. coli was introduced into Rhodopseudomonas pulsetris, and CrtI activity was carried out in the presence of arsenic. By reviving the above, an arsenic-responsive biosensor that does not require a shaking incubator has been developed (Patent Document 1).

Japanese Patent Application No. 2007-340804

Wilson T, Hastings JW (1998) Bioluminescence Annu Rev Cell Dev Biol 14: 197-230 Stocker J, Balluch D, Gsell M, Harms H, Feliciano J, DaunertS, Malik KA, van der Meer JR (2003) Environ Sci Technol37: 4743-4750 Trang PT, Berg M, Viet PH, van MuiN, van derMeer JR (2005) Environ SciTechnol 39: 7625-7630 Tsien RY (1998) Ann Rev Biochem 67: 509-544 Silhavy TJ, Beckwith JR (1985) Microbiol Rev 49: 398-418 Fujimoto et al., (2006) Appl Microbiol Biotechnol 73 (2): 332-338

  Biosensors using microorganisms such as those described above have problems such as the need for culturing equipment and time, and large variations among cells. To solve these problems, cell-free biotechnology is required. Sensor development is required. An object of the present invention is to detect and / or quantify an analyte in a test sample using a sensor protein that specifically binds to the analyte and a nucleic acid that is specifically recognized by the sensor protein. It is to provide an excellent method in terms of cost, operability, and speed.

  In order to solve the above problems, the present inventors firstly used a fluorescence resonance energy transfer method, that is, a fluorescence resonance energy for detecting a change in a higher order structure of a complex molecule through an interaction between DNA and protein. We tried to develop a system using Fluorescence Resonance Energy Transfer (FRET). FRET is a phenomenon in which excitation energy is transferred from an energy donor as a donor to an energy acceptor as an acceptor. Here, it is important to select two different fluorescent molecules such that the emission energy level of the fluorescent molecule serving as a donor and the absorption energy level of the fluorescent molecule serving as an acceptor overlap (FIG. 24). When an acceptor is present near an excited donor, the excitation energy excites the acceptor before light emission from the donor occurs, and the light emission can be detected. Since FRET is more likely to occur as the distance is shorter, it is used as a means for detecting interaction between molecules and structural change of molecules.

  Therefore, it was decided to study a biosensor using the lead and cadmium sensor protein ZntR. E. coli has a gene zntA that encodes an enzyme that functions to discharge heavy metals out of the cell. The base sequence of promoter region DNA (hereinafter referred to as promoter DNA) exists in the region of −10 bases and −35 bases upstream from the transcription start point of zntA, and lead and cadmium sensor protein ZntR binds to this promoter DNA. , A ZntR protein-promoter DNA complex is formed. In the absence of heavy metals such as lead and cadmium compounds, the promoter DNA is bent as a higher-order structure. On the other hand, in the presence of heavy metal, heavy metal binds to the ZntR protein and the higher order structure is changed, and the promoter DNA is linearized accordingly. It was considered possible to develop a heavy metal biosensor using the change in the higher-order structure of the ZntR protein-promoter DNA complex due to the presence or absence of this heavy metal.

  FIG. 25 shows the principle devised for externally presenting this higher-order structural change due to the presence or absence of heavy metals using FRET. First, fluorescein isothiocyanate (FITC) and tetramethylrhodamine (TAMRA), which are two different fluorescent substances, are bound to both ends of the promoter DNA. At this time, TAMRA absorbs and excites the fluorescence emitted by FITC by FRET and emits fluorescence. In the absence of heavy metals, the higher order structure of the promoter DNA is in a bent state, and FITC and TAMRA are close to each other. When irradiated with the excitation light of FITC, TAMRA is excited by the emitted fluorescence of FITC. It is thought that the fluorescence of TAMRA is detected. However, in the presence of heavy metals, the higher order structure of the promoter DNA changes in a linear form, so that the distance between FITC and TAMRA becomes longer, and TAMRA is less likely to absorb FITC fluorescence. Therefore, TAMRA was difficult to excite, and it was thought that the fluorescence of FITC was mainly detected. We thought that lead and cadmium compounds could be detected or quantified by measuring the change in fluorescence wavelength with or without heavy metals with a fluorometer.

  Similarly, it was decided to investigate a biosensor using the arsenic sensor protein ArsR. Escherichia coli has an arsenic resistance operon that gives cells arsenic resistance. The expression of the arsenic resistance operon is controlled by the arsenic sensor protein ArsR encoded by the gene arsR. ArsR protein binds to promoter DNA in the absence of an arsenic compound to form an ArsR protein-promoter DNA complex. Therefore, RNA polymerase cannot bind to promoter DNA, and transcription of the arsenic resistance operon is suppressed. However, in the presence of an arsenic compound, the ArsR protein and arsenic compound bind to each other and their higher-order structure changes and the ArsR protein dissociates from the promoter DNA, so RNA polymerase binds to the promoter DNA and transcription of the arsenic resistance operon begins. Is done. It was considered possible to develop a biosensor for detecting arsenic compounds by externally presenting changes in binding and dissociation between ArsR protein and promoter DNA depending on the presence or absence of such arsenic compounds.

  Furthermore, a system was proposed in which changes in binding and dissociation between protein and DNA were externally presented by FRET, as in the case of using the ZntR protein (FIG. 26). First, TAMRA is bound to one end of the promoter DNA. In addition, an ArsR-GFP fusion protein in which a green fluorescent protein (GFP) was fused to the ArsR protein was used to fluorescently modify the ArsR protein. At this time, it was thought that TAMRA absorbed and excited the fluorescence emitted by GFP by FRET. In the absence of an arsenic compound, the promoter DNA and the ArsR-GFP fusion protein are in a combined state, and TAMRA and GFP are close to each other. Therefore, TAMRA is excited by the fluorescence of GFP emitted when irradiated with GFP excitation light. Then, mainly TAMRA fluorescence is detected. However, in the presence of an arsenic compound, the promoter DNA chain and the ArsR-GFP fusion protein are in a dissociated state, so that the average distance between TAMRA and GFP becomes long, and TAMRA hardly absorbs GFP fluorescence. Therefore, TAMRA is difficult to excite and GFP fluorescence is mainly detected. It was considered that the arsenic compound can be detected or quantified by measuring the change in the fluorescence wavelength due to the presence or absence of the arsenic compound with a fluorometer.

However, as is clear from the comparative examples described later, the FRET method cannot solve the problem of the present invention. Accordingly, the present inventors are forced to develop different approaches, and pay attention to ArsR protein, which is a sensor protein that binds to arsenic, and CadC protein, which is a sensor protein that binds to cadmium and lead. ArsR-GFP and CadC-GFP fused with fluorescent protein (GFP) were prepared. It was confirmed that these fusion proteins bind to each specific recognition sequence DNA and that their binding is inhibited by metal ions. Next, to produce a recognition sequence _DNA (P ars -DNA) immobilized plate of ARSR protein, the binding of ARSR-GFP to ArsR-GFP _P ars -DNA immobilized plate, arsenite As a result, the present invention has been completed.

That is, the present invention
(1) A method for detecting or quantifying an analyte in a test sample in an aqueous system, comprising the following steps (A) and (B): (A) Specific binding to the analyte Reacting a sensor protein with a nucleic acid immobilized on a support containing a sequence specifically recognized by the sensor protein in the presence of a test sample;
(B) detecting or measuring a sensor protein bound to the immobilized nucleic acid;
(2) The method according to (1) above, wherein the sensor protein is labeled with a detectable marker,
(3) The method according to (1) above, wherein the sensor protein is a fusion protein with a detectable marker protein,
(4) A method for detecting or quantifying an analyte in a test sample in an aqueous system, comprising the following steps (A) and (B): (A) The above-mentioned solid-phased on a support Reacting a sensor protein that specifically binds to an analyte and a nucleic acid containing a sequence specifically recognized by the sensor protein in the presence of a test sample;
(B) a step of detecting or measuring nucleic acid bound to the immobilized sensor protein;
(5) The method according to (4) above, wherein the nucleic acid is labeled with a detectable marker.

The present invention also provides
(6) The method according to any one of (1) to (5) above, wherein the binding between the sensor protein and the nucleic acid is inhibited by the analyte,
(7) The method according to any one of (1) to (6) above, wherein the sensor protein is a protein encoded by a metal responsive operon,
(8) The method according to (7) above, wherein the protein encoded by the metal responsive operon is ArsR protein or CadC protein,
(9) The method according to any one of (1) to (8) above, wherein the analyte is a heavy metal compound,
(10) The method according to (9) above, wherein the heavy metal compound is selected from arsenic (As) compounds, cadmium (Cd) compounds, and lead (Pb) compounds,
(11) The method according to (10) above, wherein the pentavalent arsenic (As (V)) compound is reduced to a trivalent arsenic (As (III)) compound in advance,
(12) The above (9) to (9), wherein the reaction between the sensor protein and a nucleic acid containing a sequence specifically recognized by the sensor protein is performed in a phosphate buffer (pH 7.4) of 50 mM or more. (11) any one of the methods,
(13) Any of (9) to (11) above, wherein the reaction between the sensor protein and a nucleic acid containing a sequence specifically recognized by the sensor protein is performed in a 40 mM or more sodium chloride solution. Relates to the described method.

Furthermore, the present invention provides
(14) A test protein comprising: a sensor protein that specifically binds to an analyte; and a nucleic acid immobilized on a support that includes a sequence that is specifically recognized by the sensor protein. A kit for detecting or quantifying an analyte in a sample, or (15) a nucleic acid comprising a sensor protein that specifically binds to an analyte immobilized on a support and a sequence that is specifically recognized by the sensor protein And a kit for detecting or quantifying an analyte in a test sample. The embodiment of the present invention is characterized in that the sensor protein is labeled with a detectable marker, or the sensor protein is a fusion protein with a detectable marker protein. And the kit characterized in that the nucleic acid is labeled with a detectable marker.

  Furthermore, in an embodiment of the present invention, any of the kits described above, wherein the binding between the sensor protein and the nucleic acid is inhibited by the analyte, or the sensor protein is encoded by a metal responsive operon. Any of the kits described above, wherein the kit is characterized by being a protein, or the kit encoded by a metal-responsive operon is an ArsR protein or a CadC protein, or the analyte is arsenic (As ), Cadmium (Cd), lead (Pb), and other heavy metal compounds.

It is a figure which shows the transcriptional control mechanism of the harmful metal tolerance operon of bacteria. When no harmful metal ions are present in the environment, expression of the sensor protein gene and its downstream gene is suppressed by binding of the sensor protein to the promoter DNA. It is a figure which shows the principle of the harmful metal biosensor which used DNA as the element. It is a figure which shows the component of the arsenic compound biosensor which used DNA as the element. For recombinant ArsR-GFP production, It is a figure which shows the preparation procedure of the plasmid (pETarsRgfp) introduce | transduced into E. coliBL21 (DE3) (pLysS). It is a diagram illustrating the dissociation of the complex by complex formation and arsenite addition of _P ars-DNA and ARSR-GFP protein by native -PAGE. It is a figure which shows the result of having analyzed the protein after adding to _Pars -DNA fixed well by electrophoresis. Lane 1, fraction obtained by adding the crude protein extract to the well and removing the extract after the reaction and washing the well, then recovering the bound protein; Lane 2, adding the protein crude extract to the well and extracting after the reaction The fraction from which the solution was removed and the well was washed, and then the protein was collected; Lane 3, protein extract; Lane 4, molecular weight marker. Due to changes in the protein租抽exudates amount to be added _is a graph showing changes in ARSR-GFP protein binding amount to P ars-DNA-immobilized plate. It is a figure which shows the detection result of arsenous acid by the biosensor which used _Pars -DNA as an element. * Indicates P <0.05 and ** indicates a significant difference of P <0.005. It is a figure which shows the change of the Pars-ArsR-GFP complex amount by washing | cleaning conditions (buffer solution). Each measured value represents the fluorescence intensity measured after completion of each washing. It is a figure which shows the flow of a reduction process to pentavalent arsenic As (V) to trivalent arsenic As (III). It is a figure which shows the difference in the response with respect to the arsenic according to form of ArsR-GFP. The graph represents the average value ± standard deviation of n = 3. It is a figure which shows the detection result of As (V) by a sodium thiosulfate reduction process. Both arsenic concentrations were 100 μg / L. The graph represents the average value ± standard deviation of n = 3. It is a figure which shows the influence which the difference in a buffer solution and pH has on arsenic detection. The buffer pH at the time of preparation is indicated. A graph shows the average value +/- standard deviation of n = 3. It is a figure which shows the standard curve of ArsR-GFP in As (III) detection. The plot shows the mean value ± standard deviation of n = 3. R ² = 0.95. It is a figure which shows the examination result of the cross response of an arsenic sensor. The graph evaluates the fluorescence intensity of the sample with no metal added (−) as 1, and shows the average value ± standard deviation of n = 3. For production of recombinant CadC-GFP protein It is a figure which shows the preparation procedure of the plasmid (pETcadCgfp) introduce | transduced into E. coliBL21 (DE3) (pLysS). Is a diagram illustrating the dissociation of the complex by complex formation and 2 Atainamari addition of _P cad-DNA and CADC-GFP protein by native -PAGE. It is the schematic which shows confirmation of the complex formation of Pcad and CadC-GFP in a microplate. E1 and E2 are wells to which Pcad34 is immobilized, and E3 is a well that is not immobilized. It is a figure which shows the analysis result of the protein which remains in a Pcad34 fixed well. See FIG. 18 for samples in lanes 1, 3, and 4. Lane 2 is a crude protein extract containing CadC-GFP, Lane 5 is a molecular weight marker (Presteined Protein Marker, Broad Range (6-175 kDa), New England Biolabs) It is a figure which shows the change of the amount of CadC-GFP binding according to the addition density | concentration to the well of Pcad34. It is a figure which shows the examination result of the addition amount of the protein crude extract containing CadC-GFP. The upper figure was measured after addition to the Pcad34 immobilized well. The figure below was measured after washing the wells twice. The plot shows the mean value ± standard deviation of n = 3. It is a figure which shows the influence which NaCl addition before incubation has on the detection test of lead. A graph shows the average value +/- standard deviation of n = 3. It is a figure which shows the standard curve of CadC-GFP in Pb (II) and Cd (II) detection. The plot shows the mean value ± standard deviation of n = 3. * And ** indicate that there is a significant difference between 0 μg / L at the 5% level and the 1% level, respectively. It is a figure which shows the overlap of the spectrum of a donor and an acceptor fluorescent molecule when FRET occurs. It is a figure which shows the detection principle of the lead and cadmium compound via FRET in a biosensor. It is a figure which shows the detection principle of an arsenic compound via FRET in a biosensor. It is a figure which shows the outline | summary of breeding of Escherichia coli strain for ZntR protein expression of His tag non-modification. It is a figure which shows the confirmation result of recombinant ZntR protein expression. It is a figure which shows the result of the chromatogram in ZntR protein refinement | purification by a heparin column. It is a figure which shows the confirmation result of the ZntR protein in the refinement | purification fraction by a heparin column. It is a figure which shows the confirmation result of the ZntR protein contained in the partial refined product of protein. It is a figure which shows the result of EMSA using the probe DNA labeled with FITC (left) or TAMRA (right). It is a figure which shows the result of the EMSA using the probe DNA double-labeled with FITC and TAMRA. It is a figure which shows each fluorescence spectrum in the reaction liquid which mixed the double-labeled probe DNA and the ZntR protein partial refinement | purification liquid with and without Pb addition. It is a figure which shows the outline | summary of the breeding of colon_bacillus | E._coli strain | stump | stock for recombinant ArsR protein expression. It is a figure which shows the outline | summary of the breeding of the colon_bacillus | E._coli strain | stump | stock for recombinant ArsR-GFP fusion protein expression. It is a figure which shows the expression confirmation result of recombinant ArsR-GFP fusion protein. It is a figure which shows the chromatogram result which used the fluorescence intensity of _A280 and GFP in a heparin column refinement | purification as a parameter | index. It is a figure which shows the confirmation result of the ArsR-GFP fusion protein in a heparin column refinement | purification fraction. It is a figure which shows the chromatogram result which used as a parameter | index the fluorescence intensity of _A280 and GFP in ion exchange column refinement | purification. It is a figure which shows the confirmation result of ArsR-GFP fusion protein in an ion exchange column refinement | purification fraction. It is a figure which shows the result of the detection test of As using ParsR-350 probe DNA and ArsR-GFP fusion protein. It is a figure which shows the result of the detection test of As using ParsR-50 probe DNA and ArsR-GFP fusion protein. It is a figure which shows the result of the detection test of As using R773-50 probe DNA and ArsR-GFP fusion protein.

  The method for detecting or quantifying the analyte in the test sample of the present invention includes [1] a sensor protein that specifically binds to the analyte in the test sample, and a sequence that is specifically recognized by the sensor protein. A nucleic acid immobilized on a support containing a nucleic acid is reacted in the presence of a test sample, and a sensor protein bound to the immobilized nucleic acid is detected and / or measured in an aqueous system (in the presence of water). And [2] a sensor protein that is immobilized on a support and specifically binds to the analyte, and a nucleic acid containing a sequence that is specifically recognized by the sensor protein, The method is not particularly limited as long as it is a method for detecting and / or measuring a nucleic acid bound to a solid-phased sensor protein in the presence of an aqueous solution. In the method of [1] above, detection is possible. With a marker Using the identified sensor protein or a sensor protein fused with a detectable marker protein, the sensor protein that did not bind to the immobilized nucleic acid is discharged out of the system, thereby immobilizing the immobilized nucleic acid. The bound sensor protein can be detected and / or measured in an aqueous system. In the method [2] above, a nucleic acid labeled with a detectable marker is used to bind to the immobilized sensor protein. By discharging the nucleic acid that has not been present out of the system, the nucleic acid bound to the immobilized sensor protein can be detected and / or measured in an aqueous system. In addition, the test sample is not particularly limited, but preferable examples include river water containing heavy metals, sewage, well water, industrial effluent, and contaminated soil. In the case of solid matter such as contaminated soil, Liquid or water extract can be used.

  In addition, the kit for detecting or quantifying an analyte in a test sample of the present invention includes [3] a sensor protein that specifically binds to the analyte, and a sequence that is specifically recognized by the sensor protein. A kit for detection or quantification of an analyte in a test sample, characterized by comprising a solid phase immobilized nucleic acid on a support, and [4] binding specifically to the analyte and fixing to the support. Particularly limited as long as it is a kit for detecting or quantifying an analyte in a test sample, characterized by comprising a phased sensor protein and a nucleic acid containing a sequence specifically recognized by the sensor protein However, in the kit of [3] above, a sensor protein labeled with a detectable marker or a sensor protein fused with a detectable marker protein is used. The sensor protein bound to the activated nucleic acid can be detected / measured. In the kit of [4] above, the immobilized sensor protein can be obtained by using a nucleic acid labeled with a detectable marker. Bound nucleic acid can be detected / measured.

  The sensor protein used in the method for detecting and / or quantifying the analyte in the test sample of the present invention is a protein that can specifically bind to a nucleic acid containing a predetermined sequence, and depends on the predetermined analyte. A sensor protein encoded by a metal-responsive operon can be cited as a good example, as long as it is a protein that inhibits binding to the nucleic acid. The metal response operon is not particularly limited, and specifically, ars encoding ArsR protein, czc encoding CzcR, cad encoding CadC, chr encoding ChrB, Examples include mer that encodes MerR1 and Merer2, pbr that encodes pbrR, and the like, and among them, ars and cad can be preferably indicated. Each sensor protein encoded by the metal responsive operon recognizes a specific metal responsive operon region DNA sequence, but in the presence of a specific metal ion, these sensor proteins bind to the metal ion and have a higher order structure. By changing, it becomes impossible to bind to DNA. For example, the ArsR protein binds to ars region DNA, but the binding is inhibited by arsenic. The CadC protein binds to cad region DNA, but the binding is inhibited by cadmium and lead.

In the method for detecting and / or quantifying the analyte in the test sample of the present invention of [1] above, the sensor protein is preferably labeled with a detectable marker, and as the detectable marker, The marker is not particularly limited as long as it is a conventionally known marker for peptide labeling. For example, radioactive isotopes such as ³² P, ³ H, ¹⁴ C, ¹²⁵ I, FITC, TAMRA, Cyber Green, dansyl chloride Specific examples include fluorescent substances such as tetramethylrhodamine isothiocyanate, biologically relevant binding structures such as biotin and digoxigenin, bioluminescent compounds, and chemiluminescent compounds. The sensor protein may be a fusion protein fused with a detectable marker protein. Examples of the marker protein include enzymes such as alkaline phosphatase and HRP, antibody Fc regions, and fluorescent substances such as GFP. Specific examples include marker proteins such as MBP, binding proteins having binding ability such as MBP, lectin, and avidin, and epitope tag proteins such as HA, FLAG, and Myc. Among them, the fusion protein ARSR-GFP the ARSR protein and GFP, as well as capable of binding _P ars-DNA are the recognition sequences ARSR protein, that the binding is inhibited in a concentration-dependent manner by arsenite Therefore, it can be used as an excellent arsenite biosensor protein in the method for detecting and / or quantifying arsenite of the present invention.

In the method for detecting and / or quantifying the analyte in the test sample of the present invention of [2] above, the nucleic acid containing a sequence specifically recognized by the sensor protein is labeled with a detectable marker. The detectable marker is not particularly limited as long as it is a conventionally known marker for nucleic acid labeling, for example, radioactive such as ³² P, ³ H, ¹⁴ C, ¹²⁵ I, etc. Isotopes, fluorescent materials such as FITC, TAMRA, Cyber Green, dansyl chloride, tetramethylrhodamine isothiocyanate, biologically relevant binding structures such as biotin and digoxigenin, bioluminescent compounds, chemiluminescent compounds, etc. Can be specifically mentioned.

  In the method for detecting and / or quantifying the analyte (analyte) in the test sample of the present invention, the support for immobilizing the sensor protein or nucleic acid is not particularly limited as long as it is a known support. Instead, specifically, plastic (polystyrene, polyamide, polyethylene, polypropylene, etc.), agarose, cellulose, hydrophilic polyvinyl alcohol, acrylate polymer, polyacrylamide glass, metal, and the like can be exemplified. In addition, the method for immobilizing the sensor protein or nucleic acid on these supports is not particularly limited as long as it is a known method. For example, the physical adsorption method, the diazo method, the peptide method (acid amide) Derivative method, carboxy chloride resin method, carbodiimide resin method, maleic anhydride derivative method, isocyanate derivative method, cyanogen bromide activated polysaccharide method, cellulose carbonate derivative method, method using condensation reagent), alkylation method, etc. A covalent bonding method such as a carrier bonding method using a cross-linking reagent can be employed, and a physical adsorption method is particularly preferable. When the sensor protein or nucleic acid is immobilized on the support, it may be indirectly immobilized via another substance. Specifically, as shown in the Examples below, nucleic acid can be immobilized on a support by labeling the nucleic acid with biotin and binding biotin and the support (plastic plate) by physical adsorption. it can.

  As described above, in the present invention, it has been shown in principle that heavy metals can be detected by a biosensor for detecting arsenic, lead and cadmium using bacterial promoter region DNA and sensor protein as elements. This sensor is a cell-free sensor that directly captures changes that occur in bacterial transcriptional switches. Green fluorescence changes between the two states, binding and dissociation, that occur between the sensor protein that constitutes the transcriptional switch and the promoter region DNA. It is characterized by capturing using fluorescence of protein (GFP) or the like. More specific description will be given below.

  In the detection / quantification method of the present invention, a sensor element is immobilized in a well of a 96-well microplate in order to make the sensor part a replaceable / detachable module. There are two possible elements to be immobilized: promoter region DNA and sensor protein. When the promoter region DNA is immobilized, the DNA can be immobilized by reacting a promoter region DNA labeled with biotin at the 3 'end in a 96-well microplate on which streptavidin is immobilized. In the well of the microplate to which the promoter region DNA is immobilized, a washing operation is performed after reacting the sensor protein-GFP solution, and the fluorescence intensity of the sensor protein-GFP that maintains the binding state with the promoter region DNA in the well This system measures with a plate reader.

  In the method of the present invention, for example, E. coli strains that produce sensor proteins ArsR-GFP and CadC-GFP, respectively, are bred to confirm that these recombinant proteins bind to promoter region DNA and heavy metals, In biosensor development using ArsR-GFP, it has been clarified that the fluorescence intensity is reduced by mixing ArsR-GFP with a sample containing As (III). Next, conditions for stabilizing the binding between the promoter region DNA and the sensor protein-GFP, or conditions for conspicuous changes in the state of binding to the complex and dissociation of the complex were examined. Furthermore, in the biosensor development using CadC-GFP, it was clarified that the fluorescence intensity decreases by mixing the sample containing Pb (II) or Cd (II) with CadC-GFP.

  As a result, first, in the detection test procedure, it is important to mix the protein crude extract containing the sensor protein-GFP with the sample, salmon sperm DNA, and buffer, and incubate at room temperature or on ice for 30 minutes. It was shown that there is. Although a method of adding a sensor protein-GFP to a well and forming a DNA-sensor protein-GFP complex first and then adding a sample to measure the degree of protein dissociation was considered, this procedure is effective. Didn't work. In addition, it was shown that the presence of 40 mM or more NaCl during the 30-minute incubation is important in making the fluorescence intensity variable noticeable during subsequent measurements.

  In the detection of arsenic, it was possible to detect As (V) in the same manner as As (III) by performing a reduction treatment with sodium thiosulfate. In this case, first, hydrochloric acid is added to make acidic conditions, then sodium thiosulfate is added, and finally neutralization is performed with sodium hydroxide. Through this process, a certain concentration of ions is present as in the case of adding NaCl to the sample. In addition, by examining the optimum pH of the buffer solution, it was confirmed that the function of the sensor element was most exhibited around pH 7.4. And it became clear that not only the pH is important but also the effect changes depending on the type of buffer used, and phosphate buffer is suitable for ArsR-GFP and trishydroxymethylaminomethane buffer is suitable for CadC-GFP. confirmed. The lower limit of detection was 5 μg / L for arsenic, 10 μg / L for lead, and 1 μg / L for cadmium, indicating that detection is possible below the drinking water reference value set by the World Health Organization. Depending on future research, higher sensitivity may be achieved. The time required for detection is expected to be completed within 40 minutes, including the initial 15 minute incubation of the sample and protein extract. Both ArsR-GFP and CadC-GFP did not show cross-responsiveness to other metals of 100 μM, and were found to selectively respond to the target metal.

  EXAMPLES Hereinafter, although an Example demonstrates this invention more concretely, the technical scope of this invention is not limited to these illustrations.

[Principle of biosensor]
We attempted to develop a harmful metal biosensor using the interaction between fluorescently labeled sensor protein and DNA. As shown in FIG. 1, sensor proteins such as ArsR protein and CadC protein have a function of controlling transcription activity of harmful metal-resistant operons in E. coli and S. aureus. These proteins bind to promoter DNA in the absence of harmful metal ions to form a sensor protein-promoter DNA complex. A biosensor for the detection of arsenic, lead and cadmium compounds has been developed using the properties of the sensor protein as described above. FIG. 2 shows the principle of the biosensor.

For the immobilization of DNA on the substrate surface, attention was paid to two substances, biotin which is a low molecular vitamin and streptavidin which is a basic glycoprotein. The bond formed between these substances has a very high binding constant of 10 ¹⁵ M ⁻¹ or more, and is close to irreversible. The reason for paying attention to this binding is that the DNA strand can be modified with biotin, that streptavidin can be immobilized on a 96-well microplate substrate, and is widely used in enzyme-linked immunosorbent methods. This is because the bond is considered advantageous in that the bond does not directly affect the DNA strand. Furthermore, since a multi-sample can be processed at once by using a 96-well microplate, the construction of a detection system for high-throughput screening can be expected. A 96-well microplate modified with streptavidin (Reacti-Bind Streptavidin High Binding Capacity Coated 96-Well Plates: PIERCE) was adopted as the substrate. The fluorescence intensity was measured using a corona fluorescence microplate reader MTP-601Lab (Hitachi High-Technologies Corporation). The measurement conditions were 490 nm for the excitation filter and 530 nm for the fluorescence measurement filter, and the detection sensitivity was “AUTO”.

[Components of biosensor]
The components of an arsenic compound biosensor are shown in FIG. In E. coli, the arsB and arsC genes encoding the arsenic extracellular efflux pump and the arsR gene encoding the ArsR sensor protein form an operon in the order of arsR-arsB-arsC, and the transcriptional activity is controlled by the ArsR protein. For the arsenic compound biosensor, ArsR-GFP fusion protein and promoter region DNA ( _Pars -DNA) consisting of 50 base pairs centered on the ArsR protein binding site (operator sequence) upstream of the arsR gene were selected. For the promoter region DNA, equal amounts of ParsR-50-S-3-B (SEQ ID NO: 1 shows the sequence of ParsR-50-S) and ParsR-50-A (SEQ ID NO: 2) shown in Table 1 are mixed. A double-stranded DNA labeled with biotin at the 3 ′ end downstream of the promoter sequence (indicated as Pars-biotin) was formed. Next, Pars-biotin was prepared to a concentration of 25 pmol / 100 μL and used for immobilization.

On the other hand, in S. aureus, the cadA gene encoding the extracellular efflux pump of lead and cadmium and the cadC gene encoding the CadC sensor protein form an operon in the order of cadC-cadA, and the transcription is controlled by the CadC protein. . As a biosensor for lead and cadmium compounds, a CadC-GFP fusion protein and a promoter region DNA (P _cad -DNA) consisting of 34 base pairs centered on a CadC protein binding site (operator sequence) upstream of the CadC gene were selected. . Regarding promoter region DNA, PcadC34-S-3-B (SEQ ID NO: 3 shows the sequence of PcadC34-S) and PcadC34-A (SEQ ID NO: 4) shown in Table 2 are mixed in equal amounts, and 3 downstream of the promoter sequence. 'A double-stranded oligonucleotide labeled with biotin at its end (denoted as Pcad34-biotin) was formed. Next, Pcad34-biotin was prepared and immobilized so as to have a concentration of 20 pmol / 100 μL.

[Experimental materials and methods]
(1) Strain (Escherichia coli strain)
JM109 and DH5α (TaKaRa) were used for gene cloning. For production of recombinant protein, BL21 (DE3) pLysS (Novagen), in which the arsR gene of E. coli K12 was inserted in the same reading frame as the Acgfp1 gene, upstream of the Acgfp1 gene of pAcGFP1 plasmid DNA, was used. In addition, LB medium was used for culturing the transformant, and if necessary, ampicillin (Amp) and chloramphenicol (Cm) were added to final concentrations of 50 μg / mL and 34 μg / mL, respectively.

(2) Amplification of arsR, cadC and Acgfp1 base sequences by PCR Pfx50 DNA Polymerase (manufactured by Invitrogen) was used for the polymerase chain reaction (PCR). AcadR of Escherichia coli K12, cadC encoded by pI258 which is an endogenous plasmid DNA of S. aureus NCTC50581, and Acgfp1 encoded by pAcGFP1 plasmid DNA (manufactured by Clontech) were amplified.

(3) Reagent Arsenic acid used sodium metaarsenite 98% (As (III)) (manufactured by Sigma), divalent lead used lead acetate (II) trihydrate special grade (manufactured by Wako Pure Chemical Industries). .

(4) Plasmid DNA
When cloning DNA fragments amplified by PCR, pGEM-T vector plasmid DNA (manufactured by Promega) is used. When preparing expression units for recombinant protein production, pET-3a plasmid DNA (manufactured by Novagen) is used. Each was used.

(5) Recombinant protein production conditions and preparation method BL21 (DE3) pLysS transformant for expression of recombinant protein was cultured at 37 ° C overnight in 5 mL of medium supplemented with Amp and Cm (Amp ⁺ Cm ⁺ LB). After culturing, the obtained overnight culture solution was inoculated into 0.5 mL of Amp ⁺ Cm ⁺ LB. This was cultured at 37 ° C. for about 12 hours without adding isopropyl-β-D-thiogalactopyranoside (IPTG). After culturing, the cells were collected and washed twice with 50 mM Tris-HCl buffer (Tris-HCl, pH 7.4), and then 4 mL of cell disruption buffer (Tris-HCl containing 15% glycerol). And freeze-thawed once at -80 ° C. After sonication, the mixture was centrifuged at 15000 rpm for 15 minutes, and the resulting supernatant was used as a recombinant protein crude extract. This crude protein extract was stored frozen at −80 ° C. and thawed for use during testing. When detecting arsenous acid (As (III)) using a microplate, 10 mM phosphate buffer (PBS, pH 6.0) was used instead of the above-mentioned Tris-HCl. At the time of ultrasonic disruption, the cells were suspended in 2 mL of a cell disruption buffer (PBS containing 15% glycerol).

(6) Gel shift method (Electrophoresis Mobility Shift Assay; EMSA)
Promoter DNA, recombinant protein, and metal ion were mixed in the composition shown in Table 3, and incubated on ice for 3 hours (test using ArsR-GFP) or 1 hour (test using CadC-GFP). 5 μL of the native PAGE sample buffer shown in Table 4 was added to the reaction solution to make a total of 25 μL. Thereafter, the GFP fusion protein was visualized by irradiating the gel in which the DNA and protein in the reaction solution were developed by native PAGE with blue light by LED light source visualization (AE-6935B, manufactured by ATTO) under dark conditions.

(7) Arsenic acid (As (III)) detection test using microplate 30 μmol of 110 μL of DNA immobilization buffer (Tris buffer containing 0.05% Tween20-saline (TBS)) P _ars-DNA the dissolving solution microplates (Reacti-Bind Streptavidin Coated High Binding Capacity (HBC) Black 96-well plates, Pierce Ltd. Co.) by adding to and incubated for 2 h at room temperature, the well surface _Pars -DNA was immobilized. After washing twice with 200 μL of DNA immobilization buffer, it was washed once with 200 μL of TBS. The crude protein extract and arsenous acid solution were mixed in the composition shown in Table 5 and incubated on ice for 2 hours. Thereafter, the mixed solution was added to the plate and incubated at room temperature for 1 hour. The supernatant was removed, and washing was performed 3 times with 200 μL of washing buffer (10 mM PBS containing 0.05% Tween 20, pH 6.0). Finally, 150 μL of 50 mM Tris-HCL (pH 7.9) was added, After 10 minutes, the fluorescence intensity was measured with a Fluorescent Microplate Reader MTP-601Lab (Corona-Hitachi High-Technologies Corporation). In this case, a bandpass filter having a wavelength of 492 nm on the excitation light side and a wavelength of 530 nm on the detector side was used.

[Results and discussion: Arsenite biosensor]
(1) Preparation of ArsR-GFP fusion protein First, PCR was performed using pAcGFPrsR as a template in which the arsR gene of E. coli K12 was inserted upstream of the Acgfp1 gene of pAcGFP1 plasmid DNA in the same reading frame as the Acgfp1 gene, and arsR and Acgfp1 were The containing DNA fragment, arsRgfp, was amplified. Primers used at this time consisted of 20 bases complementary to the 5 ′ end of the arsR gene and the 3 ′ end of the Acgfp1 gene, and an NdeI site was added to the 5 ′ side thereof. pGEMarsRgfp was obtained by inserting and cloning arsRgfp into pGEM-T vector plasmid DNA (FIG. 4). The arsRgfp excised from the plasmid DNA by digesting pGEMarsRgfp with NdeI was separated and recovered by agarose gel electrophoresis. pET-3a was digested with Nde1 and joined to the collected arsRgfp to obtain pETarsRgfp. An EssR-GFP fusion protein producing strain was bred by transforming E. coli BL21 (DE3) pLysS with pETarsRgfp.

(2) Functional evaluation of ArsR-GFP fusion protein It was confirmed by the gel shift method whether the recombinant protein obtained in this way has functionality as ArsR protein. In the gel shift method, when protein and nucleic acid form a complex through a specific bond, there is a difference in the migration distance of each molecule during electrophoresis compared to the case of nucleic acid or protein alone, and the position of the band on the gel. Differences occur. This makes it possible to determine the presence or absence of specific binding between the protein and the nucleic acid. ARSR-GFP protein protein crude extract and a _P ars result -DNA were mixed, as shown in FIG. _5, bands were confirmed to be inferred that P ars -ArsR-GFP conjugate. _Further, when the electrophoresed reaction of protein crude extract without the addition of P ars-DNA, since this band is not confirmed, confirmed that this band is of _P ars -ArsR-GFP conjugate It is done. Also, the addition of arsenite to the reaction solution, a band of P _{ars -ArsR-GFP} conjugate as the concentration of the added arsenic trioxide increases that becomes thin was confirmed. These results, ARSR-GFP protein to form a _P ars-DNA specifically bound to the complex, that binding of the _P ars-DNA is inhibited was confirmed by the presence of arsenite . Furthermore, these results indicate that the function of ArsR protein is not impaired by GFP fluorescence modification.

(3) a microplate were added protein crude extract containing ARSR-GFP protein immobilized wells developed P _ars-DNA of arsenite detection system using, _P ars -ArsR-GFP complex on the well surface The body was formed. Thereafter, the protein crude extract was removed and the protein in the well was denatured and recovered with a sample buffer for SDS-PAGE without washing. As a result of analysis by electrophoresis, a dark band was detected at the position of the estimated molecular weight of 41.8 kDa of the ArsR-GFP protein, but a plurality of other bands were confirmed (lane 2 in FIG. 6). Similar analysis, when performed on samples collected after the washing to form a P _{ars -ArsR-GFP} complex on the well surface, the protein was almost completely purified position of ARSR-GFP was confirmed (FIG. 6, lane 1). In any sample of lanes, the purification of the target protein progressed dramatically compared to the case where the crude protein extract was developed as it was (FIG. 6, lane 3). From the above results, the _P ars-DNA was immobilized on the well surface, simply incubate the addition of protein crude _extract, it can also bind with the well surface while maintaining high specificity P ars-DNA and ARSR-GFP It was shown that. This result further indicates that complicated column operation for protein purification is unnecessary, and it is possible to reduce the cost for producing a biosensor.

(4) ArsR-GFP amount of containing protein crude extract Next, after immobilizing the P _ars-DNA to the well surface, the change in protein crude extract volume to be added, which fluorescence intensity remaining after the wells washing We examined how it changed. The horizontal axis the amount of liquid 100mL liquid amount per crude protein extract in the well of Figure 7, the vertical axis represents the fluorescence intensity of ARSR-GFP forming a complex with _P ars-DNA on the wells. The fluorescence intensity increased as the amount of the crude extract increased, but reached a plateau at 40 mL. This is in order to form a complex with ARSR-GFP for almost all _P ars-DNA immobilized in the wells surface sufficient amount of liquid protein crude extract of 100mL liquid amount per 40mL It shows that there is. The case of adding more of the amount of the extract, the free ARSR-GFP protein will be present in excess amount in the reaction system, free ARSR-GFP is P _ars present excessively in detecting arsenite -It is also predicted that the detection sensitivity is lowered by binding to DNA. Accordingly, arsenite was detected by provisionally applying an amount of ArsR-GFP corresponding to 40 mL of the crude protein extract.

  In detecting arsenous acid, a crude extract was prepared by concentrating an amount corresponding to 40 mL of the above-described crude protein extract to 5 mL. The crude protein extract and arsenous acid were mixed at a ratio of 5:95, and the fluorescence intensity was measured after 3 hours according to the procedure described in [Experimental materials and methods] of Example 2. As a result, a significant decrease in fluorescence intensity was observed with the addition of arsenous acid, and the decrease width was observed to be larger at 100 μg / L than at 50 μg / L. It was shown that a biosensor for detection of arsenite using DNA using a microplate as an element can detect 50 μg / L arsenite in principle (FIG. 8).

(5) Examination of washing conditions As described above, it was determined that a complex composed of Pars and ArsR-GFP serving as a sensor element could be constructed on a 96-well microplate. In addition, when the excess ArsR-GFP protein solution was removed from the Pars-immobilized well and washed with 10 mM PB-T shown in Table 6, a decrease in fluorescence intensity derived from GFP in the well was observed each time the washing was repeated. It was. This decrease was thought to be due to ArsR-GFP being dissociated from Pars by the washing operation, so that the sensor element complex was maintained on the substrate, and excess ArsR-GFP and contaminating proteins could be excluded from the system. It was thought that a proper cleaning condition was necessary. Therefore, using ArsR-GFP, washing operation was performed with the following two buffer solutions having different pH values (Table 6), and the degree of decrease in fluorescence intensity was examined.

  In a single washing operation, 200 μL of buffer solution was added to the well, and a 96-well microplate was held in the hand and shaken gently for 5 seconds to shake off the buffer solution. Again, 200 μL of buffer solution was added to the wells to measure fluorescence. This operation was repeated 4 times. Finally, 100 μL of TBS-T (Table 6) was added to all wells, and the fluorescence intensity was measured at pH 7.4 (FIG. 9).

  Fluorescent proteins such as GFP are known to have a property that the fluorescence intensity changes depending on the pH. In the case of GFP, it is known that the fluorescence intensity increases as the pH increases near neutrality. The fluorescence intensity of the 1st to 3rd washings with PB-T was measured under a weakly acidic pH of 6.0, and thus was obtained by washing with TBS-T under a weakly basic pH of 7.4. It is conceivable that it is lower than the fluorescence intensity. A decrease in fluorescence intensity was observed each time the number of washings was repeated for the two buffer solutions. After the fourth washing operation, TBS-T having a pH of 7.4 was added to adjust the fluorescence intensity to 7.4. Then, in the cleaning with PB-T, the fluorescence intensity at the end of the first cleaning of TBS-T was almost the same value. Since the decrease rate of the complex by the washing operation was smaller in PB-T than in TBS-T, it was judged that PB-T was more suitable as a washing buffer. In the subsequent tests, PB-T (pH 6.0) was adopted as the washing buffer, and the number of times and the time during washing were appropriately changed and used.

(6) Examination of Arsenic Reduction Process The sensor protein ArsR has different affinity for trivalent arsenic As (III) and pentavalent arsenic As (V), which are inorganic arsenic, respectively, and As (III ) Is known to have a high affinity. However, the arsenic indicated by the drinking water reference value does not distinguish between arsenous acid and arsenic acid, and the arsenic of As (III) and As (V) is equivalent with the sensor using ArsR-GFP as an element. It is preferable to detect. Therefore, it was investigated whether As (V) can be detected as equal to As (III) by reducing As (V) to As (III). In the test, sodium arsenate was used as As (V), sodium arsenite as As (III), and sodium thiosulfate as the reducing agent.

  The sample reduction treatment was performed according to the procedure shown in FIG. 20.0 μL of 2N hydrochloric acid solution was added to 450 μL of the sample to bring the pH to around 1. Next, 1.0 μL of a 250 mM sodium thiosulfate aqueous solution prepared for use was added, followed by incubation at room temperature for 10 minutes. Ten minutes later, 16.0 μL of 2.5N sodium hydroxide solution was added for neutralization. The pH was confirmed using a pH test paper.

  Prepare 92 μL of the sample that was prepared with As at a predetermined concentration and did not undergo the reduction treatment, or 7.5 μL of the crude protein extract containing ArsR-GFP and 0.5 μL of 10 mg / mL salmon sperm DNA. Incubation for 30 minutes on ice was performed. Thereafter, the mixed solution was added to the Pars-immobilized well and shaken at room temperature for 2 hours. After 2 hours, the mixed solution in the well was removed, and washing was performed once for 5 seconds with 200 μL of PB-T (Table 6). After washing, 150 μL of a fluorescence measurement buffer solution (50 mM Tris-HCl pH 7.9, 1 M NaCl, 0.1% (w / v) Tween-20) was added to the well, and fluorescence measurement was performed.

  In a sample containing a predetermined concentration of As that was not subjected to reduction treatment, the decrease in fluorescence intensity increased in correlation with the concentration in As (III), but the decrease in fluorescence intensity almost decreased at 100 μg / L in As (V). It was not seen (FIG. 11). However, a reduction in fluorescence intensity equivalent to that of As (III) was observed in As (V) by performing the reduction treatment (FIG. 12). In addition, when the fluorescence intensity when using ultrapure water as a sample is compared with and without the reduction treatment, no significant difference is observed, indicating that the reduction treatment itself does not affect the detection.

  The developed arsenic sensor ArsR-GFP showed no change in fluorescence intensity even at 100 μg / L As (V), confirming that ArsR-GFP has extremely low response to As (V). It was. However, the reduction treatment with sodium thiosulfate showed a change in fluorescence intensity equivalent to that of As (III). Therefore, the sensor was connected to As (V) through the reduction from As (V) to As (III). Was also found to be detected in the same manner as As (III). Although not shown in the data, it has become clear that As (V) cannot be detected unless the sodium thiosulfate treatment is performed after setting the pH to a strongly acidic range in the reduction treatment. Therefore, it is considered essential to add an acid such as hydrochloric acid in the reduction treatment.

(7) Optimization of the buffer solution added to the sample and its pH after the reduction treatment Since the developed arsenic sensor element is a protein, the element itself may denature under extreme pH conditions and may not function as a sensor. is there. Therefore, it is considered necessary to bring the pH close to the optimum pH at which the function as a sensor is exhibited for any pH sample. Therefore, the influence of pH during the arsenic detection test was confirmed. In the detection test, 445 μL each of a sample not containing arsenite and a sample containing 100 μg / L As (III) was added to 20.0 μL of 2N hydrochloric acid, 5.0 μL of 500 mM ethylenediaminetetraacetic acid (pH 8.0), 250 mM. Reduction treatment was performed by sequentially adding 1.0 μL of sodium thiosulfate and 16.0 μL of 2.5N sodium hydroxide. Thereafter, 25.0 μL of the buffer solution shown in Table 7 was added, and the influence of the pH condition of the sample was examined. In order to increase the buffer capacity of the buffer, the concentration was 1 M (final concentration 50 mM).

  The sample after adding each buffer solution, the crude protein extract containing ArsR-GFP, and salmon sperm DNA were mixed and incubated on ice for 30 minutes. Thereafter, the mixed solution was added to the Pars-immobilized well and shaken at room temperature for 2 hours. Excess ArsR-GFP protein solution in the wells was removed and washed once with 200 μL of PB-T (Table 6) for 5 seconds. After washing, 150 μL of fluorescence measurement buffer was added to the well, and the fluorescence intensity was measured (FIG. 13).

  Comparing the three conditions of the phosphate buffer, as the pH increases, the amount of Pars-ArsR-GFP complex formed increases in the condition where arsenous acid is not added, and further fluorescence with a sample containing 100 μg / L of As (III) The decrease in strength also increased. However, comparing the two conditions at pH 7.4, it was found that the signal from the sensor was weakened in the Tris buffer because the decrease was reduced. This result suggests that different results can be obtained even if the arsenic concentration is the same unless the arsenic detection test is performed at a constant pH. It is considered indispensable to adjust the pH of the sample by using a buffer solution or the like. From the results shown in FIG. 13 and FIG. 9, when the pH of the sample is kept constant, the phosphate buffer solution having a high buffer capacity of about 1M is used to bring the pH to around 7.4 and the final phosphate buffer concentration to 50 mM or more. It is deemed appropriate to perform an arsenic detection test after adjustment.

(8) Standard curve for arsenic detection A detection test for arsenous acid was carried out under the washing and fluorescence intensity measurement conditions obtained in the previous tests. After the reduction treatment of the sample by the method carried out in “(7) Buffer solution added to sample after reduction treatment and optimization of its pH”, 25 μL of 1M phosphate buffer solution at pH 7.4 was added. 95 μL of the treated sample thus obtained and 4.5 μL of ArsR-GFP solution and 0.5 μL of 10 mg / mL salmon sperm DNA were mixed and incubated on ice for 30 minutes. The mixture was added to Pars-immobilized wells 30 minutes later and shaken at room temperature for 10 minutes. After 10 minutes, the excess liquid mixture was removed, and washing was performed once for 5 seconds with 200 μL of PB-T (Table 6). After washing, 150 μL of 50 mM trishydroxymethylaminomethane-HCl, pH 7.9 was added to the well, and fluorescence measurement was performed. A standard curve of ArsR-GFP in As (III) detection is shown in FIG.

  In the test, a negative correlation was observed between the As (III) concentration and the fluorescence intensity. Further, when compared with the As (III) concentration of 0 μg / L, the fluorescence intensity showed a significant decrease at the As (III) concentration of 5 μg / L and a 50% decrease at 50 μg / L. From this result, by examining the measurement conditions, it will be shown that the developed arsenic sensor can detect 10 μg / L As (III), which is the reference value of drinking water set by the World Health Organization. I was able to.

(9) Cross-responsiveness of arsenic sensor It was confirmed that the arsenic sensor can detect the trivalent arsenic in the order of μg / L. However, it has not been shown to have selective response, which is an important element of the sensor. Therefore, we decided to investigate the responsiveness of the arsenic sensor to metals other than arsenic. Samples include 1.0 μM, 10 μM, and 100 μM calcium chloride, cadmium chloride, copper sulfate (II), iron sulfate (II), iron chloride (III), magnesium sulfate, manganese sulfate, lead (II) acetate, zinc sulfate Was tested. In simultaneous detection of As (III) and As (V), a reduction treatment of the sample with sodium thiosulfate is necessary. Therefore, in this test as well, "(7) Buffer solution added to the sample after the reduction treatment and its pH After the reduction treatment of the sample by the method performed in “Optimization”, 25 μL of 1 M phosphate buffer having a pH of 7.4 was added. Thereafter, the ArsR-GFP solution and salmon sperm DNA were mixed and incubated for 30 minutes on ice as in the previous section. After the mixture was added to the Pars-immobilized well and shaken at room temperature for 2 hours, the excess mixture in the well was removed and washed once with 200 μL of PB-T (Table 6) for 5 seconds. Went. After washing, 150 μL of a fluorescence measurement buffer solution was added to the well, and fluorescence measurement was performed (FIG. 15).

  From the arsenic detection standard curve of FIG. 14, it is predicted that the arsenic sensor exhibits a reduction range of 50% or more from the value of 0 μg / L to 1 μM (= 75 μg / L) of As (III). On the other hand, in this test result, no cross response was shown for each 100-fold concentration of each metal. From this, it was confirmed that the arsenic sensor responded to arsenic with high selectivity. From this result, it is speculated that the metal chelate action of ethylenediaminetetraacetic acid added during the reduction treatment of the sample is acting effectively in addition to the specificity that the ArsR protein originally has for arsenic.

[Results and Discussion: Lead and Cadmium Biosensors]
(1) Breeding of CadC-GFP fusion protein producing Escherichia coli strain A CadC-GFP fusion protein was produced in the same manner as in the preparation of ArsR-GFP fusion protein described in Example 3. pGEMrsRgfp was digested with SphI and BamHI, and pGEMgfp was obtained by removing the excised fragment (FIG. 16). PCR was performed using pI258 plasmid DNA as a template, and a DNA fragment containing cadC was amplified. At this time, primers were used in which SphI and NdeI sites were added to 20 bases complementary to the 5 ′ end of the cadC gene, and BamHI sites were added to 20 bases complementary to the 3 ′ end. pGEMcadCgfp was obtained by digesting cadC with SphI and BamHI and joining with pGEMgfp. The cadCgfp excised from the plasmid DNA by digesting pGEMcadCgfp with NdeI was separated and recovered by agarose gel electrophoresis. pET-3a was digested with NdeI and joined to the recovered cadCgfp to obtain pETcadCgfp. A CadC-GFP fusion protein-producing strain was bred by transforming E. coli BL21 (DE3) pLysS with pETcadCgfp.

(2) Functional evaluation of CadC-GFP fusion protein As in Example 3, whether or not the CadC-GFP fusion protein has a CadC protein function was confirmed by a gel shift method. Mixing the crude protein extract and _P cad-DNA containing CADC-GFP protein _band was confirmed to be inferred that P cad -CadC-GFP conjugate (upper Figure 17). Since this band is not confirmed when electrophoresed reaction of protein crude extract without the addition of P _cad-DNA, it is supported that the band is of the _P cad -CadC-GFP conjugate. In addition, it was confirmed that the band of the Pcad-CadC-GFP complex was thinned in any case when lead, calcium, or magnesium ions, which are divalent cations, were added to the reaction system, respectively (bottom of FIG. 17). ). However, when divalent lead was added, the band was significantly thinner than when calcium or magnesium was added, so the CadC-GFP fusion protein binds to divalent lead with a certain selectivity and P _cad -It is assumed that the binding constant or dissociation constant with DNA is changed.

(3) using a microplate microplates immobilized with lead and protein crude extract containing development CADC-GFP fusion protein cadmium detection system and P _cad-DNA using the same principle as arsenite detection system A biosensor was constructed to detect lead and cadmium compounds.

  Pcad34-biotin having a CadC binding sequence was immobilized on the E1 and E2 wells shown in FIG. No DNA strand was immobilized on the E3 well. A crude protein extract containing 100 μL of CadC-GFP was added to the wells from E1 to E3, and shaken at room temperature for 2 hours. After 2 hours, excess protein crude extract was removed. 100 μL of protein solubilization buffer (Table 8) was added to the well of E1, and after 30 minutes of shaking at room temperature, the buffer was recovered and loaded into lane 3 of electrophoresis (SDS-PAGE). Separately, 200 μL of PB-T (Table 6) was added to the wells of E2 and E3 and removed, and washing was repeated twice. Thereafter, 100 μL of protein solubilization buffer was added, and the protein remaining in the wells was solubilized by shaking at room temperature for 30 minutes, and loaded into Lane 4 and Lane 1 of electrophoresis. The recovered protein solubilization buffer was treated by incubation at 98 ° C. for 5 minutes before loading. Electrophoresis was performed under the conditions of 250 V, constant current 20 mA, and room temperature.

  As a result of electrophoresis, compared with the crude protein extract containing CadC-GFP in lane 2 in FIG. 19, CadC-GFP was concentrated in the remaining protein by contacting the crude protein extract with the well where Pcad34 was immobilized. It can be seen that it has been purified (lane 3). This is judged from the fact that the protein was recognized as the main band at the position of the molecular weight determined from the calculation of CadC-GFP. Moreover, it can be seen that by washing the wells, the contaminating protein band was further reduced and CadC-GFP was concentrated and purified (lane 4). On the other hand, when Pcad34 is not immobilized on the well, it can be seen that CadC-GFP was washed away by washing (lane 1). From this result, it was confirmed that it was possible to specifically bind CadC-GFP from the crude protein extract onto a 96-well microplate on which Pcad34 had been immobilized. Therefore, it was decided to investigate a system in which a complex of Pcad DNA and CadC-GFP sensor protein is formed on a 96-well microplate as a lead / cadmium sensor element.

(4) Examination of Pcad Immobilization Amount in Lead / Cadmium Sensor The amount of Pcad34-biotin bound to biotin at the 3 ′ end of Pcad was confirmed and used as a reference for constructing the sensor. The concentration of Pcad34-biotin was adjusted to 0 to 50 pmol / 100 μL and used for immobilization in the wells. The crude protein extract containing CadC-GFP was obtained by using 4 mL of TG (50 mM trishydroxymethylaminomethane) in 50 mL of the culture solution of E. coli BL21 (DE3) pLysS (pETcadCgfp) bred as shown in FIG. -HCl pH 7.4, suspended in 15% (v / v) glycerol) and sonicated on ice using UD-201 (Tomy Seiko Co., Ltd.) (oscillation output 3, interval 50%, 5 minutes 4) 1). 99 μL of the crude protein extract and 1.0 μL of 10 mg / mL salmon sperm DNA were mixed, added to the Pcad34-immobilized well, and shaken at room temperature for 2 hours. After 2 hours, excess protein crude extract was removed and washed twice with 200 μL of PB-T (Table 6) for 5 seconds. After washing, 150 μL of 50 mM trishydroxymethylaminomethane-HCl (pH 7.9) was added to the well, and fluorescence measurement was performed. As a result, up to 20 pmol / 100 μL, an increase in the amount of CadC-GFP binding was observed with an increase in the amount of Pcad34 immobilized (FIG. 20). Similar to the result of immobilization of Pars, the fluorescence intensity reached saturation at an immobilization amount of 20 pmol / 100 μL. Since the amount of CadC-GFP in the crude protein extract used in this test is considered to be sufficient, it is considered that the amount of Pcad34 immobilized on the well reached saturation at 10-20 pmol / 100 μL. In conclusion, in constructing a lead / cadmium sensor, the concentration of Pcad34 used for immobilization was set to 20 pmol / 100 μL as the upper limit.

(5) Examination of addition amount of CadC-GFP in lead / cadmium sensor The optimum addition amount of protein crude extract containing CadC-GFP was examined with respect to the amount of Pcad34 used of 20 pmol per well. Pcad34-biotin was prepared to 20 pmol / 100 μL, and immobilized by adding to wells. A mixed solution of 99 μL of a crude protein extract containing CadC-GFP and 1.0 μL of 10 mg / mL salmon sperm DNA was prepared. Next, the mixture was diluted with TG (50 mM trishydroxymethylaminomethane-HCl pH 7.4, 15% (v / v) glycerol) so that the volume ratio with respect to the total amount of the mixture became 0-100 μL / 100 μL. Then, this diluted sample was added to the Pcad34-immobilized well, and fluorescence measurement was performed (upper diagram in FIG. 21). Thereafter, the mixture was shaken at room temperature for 1 hour, and then the excess diluted sample was removed, followed by washing with 200 μL of PB-T (Table 6) twice for 5 seconds. After washing, 150 μL of 50 mM Tris-HCl, pH 7.9 was added to the well, and fluorescence measurement was performed (the lower diagram in FIG. 21).

  As a result, the amount of CadC-GFP bound to Pcad34 reached saturation when the volume ratio of the solution added to the well was about 80 to 90 μL / 100 μL. Regarding the crude protein extract used, it is considered that CadC-GFP is excessive with respect to 20 pmol of immobilized Pcad34 at a volume ratio of 80-90 μL / 100 μL or more. In other words, in the detection test, when the crude protein extract becomes higher than the concentration of the current volume ratio of 80 to 90 μL / 100 μL, a decrease in detection sensitivity to lead and cadmium is expected. It was decided to construct a lead / cadmium sensor based on the CadC-GFP concentration in the crude protein extract used in this test. However, as in the case of ArsR-GFP, the crude protein extract containing CadC-GFP was also contaminated with E. coli. Since it is an E. coli cell disruption solution, it is difficult to accurately calculate the CadC-GFP concentration. Therefore, it was decided to simply determine the concentration of CadC-GFP based on the fluorescence intensity of the crude protein extract at pH 7.4.

  The major difference in comparing CadC-GFP and ArsR-GFP is that saturation of binding to a certain amount of promoter region DNA strand is assumed when the fluorescence intensity of each protein solution is considered as the concentration of sensor protein-GFP. The amount required for this is different. In CadC-GFP, it is necessary to add a crude protein extract so that the product of the fluorescence intensity and the liquid volume is increased. This may be due to the fact that the binding constants of each sensor protein-GFP and the promoter region DNA chain are different, or the number of bases of Pcad34 used is insufficient. Therefore, the influence of the number of bases of Pcad in forming the complex and the influence of the salt concentration were examined.

(6) Examination of Pcad base number and salt concentration in construction of lead / cadmium sensor In order to investigate the influence of the difference in the base number of Pcad, a double-stranded DNA was newly designed. This is a Pcad34 base sequence containing a cadC binding sequence near -10 bases of the promoter common sequence upstream from the cadC transcription start site on pI258 possessed by S. aureus, plus a cadC binding sequence near -35. It is. In order to prepare a newly created double-stranded DNA, Pcad50-S-3-B (SEQ ID NO: 5 shows the sequence of Pcad50-S) and Pcad50-A (SEQ ID NO: 6) shown in Table 9 are equivalent. The mixture was mixed to form Pcad50-biotin, a double-stranded oligonucleotide labeled with biotin at the 3 ′ end of the promoter sequence. Next, Pcad34-biotin and Pcad50-biotin were prepared to 20 pmol / 100 μL and used for immobilization.

  The crude protein extract containing CadC-GFP was prepared by suspending cells in 300 mL of the culture solution in 4 mL of TG2 (200 mM trishydroxymethylaminomethane-HCl pH 7.4, 15% (v / v) glycerol) on ice. , UD-201 (Tomy Seiko Co., Ltd.) was used for ultrasonic crushing (oscillation output 3, interval 50%, 5 minutes, 4 times). When 7.5 μL of the crude protein extract, 0.5 μL of 10 mg / mL salmon sperm DNA, and 92 μL of ultrapure water were mixed to make 100 μL, the fluorescence intensity was 65.3 ± 0.6. This mixed solution was added to Pcad34 and Pcad50 fixed wells, and shaken at room temperature for 2 hours. After 2 hours, the mixed solution in the wells was removed and washed once with 200 μL of PB-T (Table 6) for 5 seconds. After washing, 150 μL of a fluorescence measurement buffer was added to the well, and fluorescence measurement was performed. As a result, the fluorescence intensity was 2.10 in the Pcad34-immobilized well and 2.06 in the Pcad50-immobilized well. Even when Pcad50 with an increased CadC binding sequence at another site was immobilized, no change was observed in the binding amount of CadC-GFP.

  Next, the influence of the salt concentration on the formation of the complex was examined. During the reaction for forming the complex, sodium chloride was added to adjust the salt concentration. In the well of the microplate, Pcad50-biotin was prepared and immobilized so as to be 20 pmol / 100 μL. In the lead detection test, in order to examine the influence of the salt concentration on the formation of the Pcad-CadC-GFP complex, first, a mixture of the sample and the crude protein extract was prepared with the composition shown in Table 10. In this case, under the sodium chloride addition condition, the lead (II) acetate solution: 4M sodium chloride becomes 99: 1 (v / v). Thereafter, a series of operations were performed in the same manner as in the previous detection tests, and the fluorescence intensity was measured.

  A decrease in fluorescence intensity was observed with an increase in the Pb (II) concentration under both conditions of no addition of sodium chloride and addition of sodium chloride (FIG. 22). However, under the sodium chloride addition condition, the fluorescence intensity at a Pb (II) concentration of 0 μg / L significantly increased. Furthermore, the difference in fluorescence intensity from the case where lead was added increased remarkably, and the fluorescence intensity decreased to about 30% at a Pb (II) concentration of 100 μg / L compared to 0 μg / L. From this result, it was clarified that the salt concentration had a great influence on the binding between CadC-GFP and Pcad. Therefore, it was effective to adjust the salt concentration to 40 mM in the lead and cadmium detection test. To be judged.

(7) Standard curve for lead and cadmium detection Lead and cadmium detection tests were conducted under the incubation conditions obtained in the previous tests. In the well of the microplate, Pcad50-biotin was prepared and immobilized so as to be 20 pmol / 100 μL. As a sample, 376 μL of a Pb (II) or Cd (II) solution having a known concentration of 0 to 100 μg / L was mixed with 4.0 μL of 4M NaCl. Furthermore, in order to make the pH of the sample constant, 20.0 μL of 1M trishydroxymethylaminomethane-HCl (pH 7.4) was added as a buffer solution to make the total amount of the sample 400 μL. Mix 92 µL of the pretreated sample with 7.5 µL of the crude protein extract containing CadC-GFP and 0.5 µL of 10 mg / mL salmon sperm DNA, and perform a series of operations in the same manner as in the previous detection tests. The fluorescence intensity was measured.

  As a result, a decrease in fluorescence intensity correlated with an increase in the concentration of Pb (II) and Cd (II) was observed (FIG. 23). Compared with 0 μg / L, a significant difference was observed in fluorescence intensity at a concentration of 10 μg / L for Pb (II) and 5 μg / L for Cd (II). As a result of conducting a more detailed test on the lower limit of detection of Cd (II), it was found to be 1 μg / L. On the other hand, it was clarified that no decrease in fluorescence intensity was observed at 75 μg / L or more for any heavy metal.

  The standard values of drinking water recommended by the World Health Organization are 10 μg / L for Pb (II) and 3 μg / L for Cd (II). Therefore, it was shown that the developed lead / cadmium sensor can detect lead at the reference value and cadmium below the reference value. Although not shown in the data, the sensors are cross-responsive to 1, 10, and 100 μM Ca (II), Mg (II), Fe (II), Mn (II), Fe (III), As (III). It became clear that almost no.

[Comparative example: FRET method]
In order to detect the change in the higher order structure of the complex molecule through the interaction between DNA and protein, we tried to develop a system using fluorescence resonance energy transfer (FRET). FRET is a phenomenon in which excitation energy is transferred from an energy donor as a donor to an energy acceptor as an acceptor. When an acceptor is present near an excited donor, the excitation energy excites the acceptor before light emission from the donor occurs, and the light emission can be detected. Since FRET is more likely to occur as the distance is shorter, it is used as a means for detecting interaction between molecules and structural change of molecules.

(1) Expression and Extraction of Recombinant Protein and Confirmation of Expression Escherichia coli transformed strain for expression of ZntR protein was cultured overnight at 37 ° C. in 5 mL of medium supplemented with Amp and Cm, and then 250 mL of medium supplemented with Amp and Cm Inoculated and cultured at 37 ° C with shaking. When OD ₆₀₀ reaches 0.6-0.8, isopropyl-β-D-thiogalactopyranoside (IPTG) is aseptically prepared to a final concentration of 0.5 mM. Furthermore, it culture | cultivated at 37 degreeC for 3 hours. The culture is centrifuged at 8000 rpm for 5 minutes to collect the cells, the supernatant is discarded, and freeze-thaw (freeze at -80 ° C. for 30 minutes and thaw for 30 minutes at room temperature) three times to obtain an appropriate amount of Tris buffer A. Resuspended in (50 mM Tris-Cl, pH 8.0, 2 mM EDTA, 5 mM dithiothreitol) and incubated at room temperature for 10 minutes. After centrifuging at 4 ° C., 12,000 rpm for 10 minutes to obtain a crude extract of ZntR protein, it was developed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) to confirm the expression of the ZntR protein.

An Escherichia coli transformant for expression of ArsR protein was cultured overnight at 37 ° C. in 5 mL of a medium supplemented with Amp and Cm, and then inoculated into 250 mL of LB medium supplemented with Amp. This was cultured with shaking at 37 ° C. until the OD ₆₀₀ was 0.8. Thereafter, IPTG was aseptically added to a final concentration of 1 mM, and cultured at 37 ° C. for 3 hours. The culture was centrifuged at 8000 rpm for 15 minutes to collect and discard the supernatant, and then resuspended in 30 mL of Tris buffer A and subjected to ultrasonic disruption to obtain an ArsR protein crude extract. This ArsR protein crude extract was developed by SDS-PAGE to confirm the expression of ArsR protein. In order to separate protein and DNA, DNase I treatment was performed. DNase I treatment was performed using RNase-free DNase I (TaKaRa), and the method was performed according to the product protocol.

  The expression of ArsR-GFP fusion protein was performed in the same manner as the expression of ArsR protein. However, only Amp was added to the medium.

  The compositions of SDS-PAGE gel, electrophoresis buffer, and sample buffer are shown in Table 11, Table 12, and Table 13, respectively. The protein solution and sample buffer were mixed 20 μL each to make 40 μL, and boiled in boiling water for 5 minutes was added to the gel and subjected to electrophoresis. As a molecular weight marker, Prestained Protein Marker, Broad Range (Bio Labs) was used. The gel after electrophoresis was immersed in a staining solution in which 0.2% (w / v) Coomassie Brilliant Blue R-250 was dissolved in 40% (v / v) methanol-10% (v / v) acetic acid aqueous solution. Then, the sample was dyed by gently shaking for 30 minutes. Decolorization was performed by gently immersing in 20% (v / v) methanol-5% (v / v) acetic acid aqueous solution (decolorizing solution). Decolorization was repeated by replacing with a new decolorizing solution until the gel was decolorized and the protein band was clear.

(2) Purification of ZntR and ArsR-GFP fusion protein All purification steps were performed in a cold room (6-8 ° C). The crude extract of ZntR or ArsR-GFP fusion protein was subjected to ammonium sulfate precipitation, and then subjected to gel filtration for desalting. Ammonium sulfate was finely ground with a pestle and mortar. Thereafter, while stirring with a stirrer, 0% → 10% → 20% → 30% → 40% → 45% was added to the crude extract and completely dissolved in each step. After reaching 45% concentration, the mixture was stirred overnight with a stirrer. Thereafter, the mixture was centrifuged at 4 ° C. and 12000 rpm for 30 minutes, the supernatant was discarded, and 1/10 amount of Tris buffer A of the crude extract was added to the precipitate to completely dissolve it. For gel filtration, PD-10 Desalting column (GE Healthcare) was used, and the method was performed according to the attached protocol. At this time, Tris buffer A was used as the buffer and elution buffer used for column equilibration.

  Thereafter, affinity chromatography was performed for the purification of the ZntR protein, and affinity chromatography and ion exchange chromatography were performed for the purification of the ArsR-GFP fusion protein. Hi Prep 16/10 Heparin FF (GE Healthcare) was used for affinity chromatography, and Hi Trap SP HP (GE Healthcare) was used for ion exchange chromatography. The method was performed according to each protocol. Each purification condition is shown in Tables 14 and 15.

The ZntR protein after purification was quantified by the Bradford method (measurement of absorbance at 595 nm (A ₅₉₅ ) after Coomassie brilliant blue staining). Smart Spec ^™ Plus Spectrophotometer (manufactured by Bio Rad) was used for absorbance measurement. Determination of ARSR-GFP fusion protein after purification _was carried out by measuring the _{A 280.} At the same time, GFP fluorescence (518 nm) was also measured. An F-2500 type spectrofluorometer (manufactured by Hitachi) was used for the fluorescence measurement.

(3) Gel shift method (Electrophoresis Mobility Shift Assay; EMSA)
Fluorescently labeled oligonucleotide chains used for EMSA are shown in Table 16 (SEQ ID NO: 7 shows the zntA-Pr-S sequence and SEQ ID NO: 8 shows the zntA-Pr-A sequence). The non-fluorescent oligonucleotide was prepared with the same base sequence as the fluorescently labeled oligonucleotide. Table 17 shows the composition of the binding reaction between the promoter DNA and the ZntR protein. When double-stranded DNA was used, complementary two single-stranded DNAs (100 μM) were mixed in equal amounts in a PCR tube and heat treated at 95 ° C. for 1 minute. After the heat treatment, it was left at room temperature for 1 hour or more to promote the formation of double strands (50 μM). In order to promote the binding between the promoter DNA and the ZntR protein, a reaction solution was prepared and then incubated at 37 ° C. for 30 minutes. The reaction solution was adjusted to 40 μL by adding a sample buffer for Native-PAGE shown in Table 18. Thereafter, Native-PAGE was performed using an acrylamide gel prepared with the composition shown in Table 19 and the TBE buffer shown in Table 20.

  Detection of fluorescently labeled DNA in EMSA was performed by photographing a gel irradiated with LED light source visualizes (ATTO, AE-6935B (blue light source), AE-6935GL (green light source)) with a digital camera under dark conditions.

(4) Lead compound detection test The promoter DNA used was double-stranded DNA labeled with FITC and TAMRA at both ends, as used in EMSA. The promoter DNA was mixed with a single-stranded DNA probe previously labeled with FITC and TAMRA and treated by the method used in EMSA to form a double-stranded DNA. As heavy metals, lead acetate (II); Pb (CH ₃ COOH) ₂ (hereinafter referred to as Pb) and zinc sulfate; ZnSO ₄ (hereinafter referred to as Zn) were each prepared at a concentration of 10 nM. As comparative objects, sodium chloride; NaCl (hereinafter referred to as Na), calcium ion; CaCl ₂ · 2H ₂ O (hereinafter referred to as Ca) were each prepared at a concentration of 10 nM. Samples were examined under 5 conditions including 1 nM Pb, 1 nM Zn, 1 nM Na, 1 nM Ca, and Tris buffer A (50 mM Tris-Cl pH 8.0, 5 mM dithiothreitol) without EDTA added. Reaction solutions were prepared with the compositions shown in Table 21 and incubated at 37 ° C. for 30 minutes under dark conditions. Thereafter, 1 mL of Tris buffer A to which EDTA was not added was added to the reaction solution and mixed, and then fluorescence measurement was performed under the conditions shown in Table 22.

(5) Arsenic Compound Detection Test GFP derived from pAcGFP1 plasmid fused with ArsR protein is a fluorescent protein emitting green fluorescence with an excitation wavelength of 475 nm and a fluorescence wavelength of 505 nm. A reaction solution was prepared by mixing three different fluorescently labeled DNA probes with ArsR-GFP fusion protein, sodium arsenite; NaAsO ₂ (hereinafter referred to as As). The three fluorescently labeled DNA probes used are shown in Table 23. As a result of examining excitation light of 350 nm, 360 nm, 370 nm, 380 nm, 390 nm, 400 nm, 410 nm, and 420 nm, the wavelengths of 350 nm and 360 nm at which the peaks of the fluorescence intensity of TAMRA and GFP changed when As was not added and when As was added were determined. Using. The fluorescence measurement conditions excluding the excitation wavelength, the fluorescence start wavelength, and the fluorescence end wavelength were the conditions shown in Table 22. All incubations were performed under light shielding conditions. A 350 bp DNA fragment centered on the promoter region on genomic DNA to which ArsR protein binds was amplified by PCR combining the primers “ParsR-S3-5-TAMRA” and “Ec arsR prm ext prm” shown in Table 23. (Hereinafter referred to as ParsR-350 probe DNA) (SEQ ID NO: 9 is the sequence of ParsR-S3, SEQ ID NO: 10 is the sequence of EcorsR prm ext prm, SEQ ID NO: 11 is the sequence of R773-50-S, SEQ ID NO: 12 shows the sequence of R773-50-A).

  A 350 bp DNA fragment centered on the promoter region on genomic DNA, to which ArsR protein binds, is amplified by PCR combining the primers shown in Table 23, ParsR-S3-5-TAMRA and EcorsR prm ext prm (hereinafter referred to as “DNA”). , Written as ParsR-350 probe DNA). Table 24 shows the reaction composition in the detection test using ParsR-350 probe DNA. After detection was performed according to the procedure shown in Table 24, the fluorescence spectrum of 1 mL of the reaction solution was measured. The detection of fluorescence was performed twice for 400-650 nm.

The double-stranded DNA formed by ParsR-50-S-5-TAMRA and ParsR-50-A shown in Table 23 is composed of a 50-bp base sequence of promoter DNA on genomic DNA to which ArsR protein binds (hereinafter referred to as “DNA”). , Written as ParsR-50 probe DNA).
The double-stranded DNA formed by R773-50-S-5-TAMRA and R773-50-A shown in Table 23 is a 50 bp base of promoter DNA on R-773 plasmid DNA to which ArsR protein binds. It consists of a sequence (hereinafter referred to as R773-50 probe DNA). These two fluorescently labeled DNA probes were incubated at 80 ° C. and then incubated at room temperature to form double-stranded DNA.

  Table 25 shows the reaction composition and the detection procedure in the detection test using ParsR-50 probe DNA or R773-50 probe DNA. The fluorescence was detected three times for 480 to 650 nm.

(6) Result of breeding of E. coli strain for expressing ZntR protein The pET3a vector was used for breeding of the E. coli strain for expressing ZntR protein. Since the recombinant ZntR protein reported previously had a His tag at the N-terminus, the possibility of binding to a heavy metal via the His tag could not be ruled out, so an E. coli strain expressing a ZntR protein without a His tag Breeding again. First, the JM109 strain carrying pET16zntR shown in FIG. 27 was inoculated into 100 mL of LB medium supplemented with Amp, and cultured overnight at 37 ° C. with shaking. On the next day, plasmids were extracted after collecting the cells. The resulting plasmid solution was reacted overnight using restriction enzymes NdeI and BamHI. The restriction enzyme reaction solution was developed by agarose gel electrophoresis, and the band of the target zntR gene fragment was cut out and purified. Ligation was performed by using this as insert DNA and incubating with the pET3a vector at 16 ° C. overnight. Escherichia coli JM109 strain was transformed using the ligation reaction solution. Five colonies selected after the transformation were designated as a, b, c, d, and e. Each of them was inoculated into 5 mL of LB medium supplemented with Amp, and cultured overnight at 37 ° C. with shaking. Next, after performing plasmid extraction using each culture solution, restriction enzyme reaction was performed at 37 ° C. for 1 hour using NdeI and BamHI. As a result of performing agarose gel electrophoresis and confirming the presence or absence of the insert, the insert was observed in the plasmid extracted from b and c. As a result of sequencing, it was confirmed that the sample of c was the target pET3zntR. Therefore, BL21 (DE3) pLysS was transformed with this plasmid. Through these processes, an E. coli strain for expressing ZntR protein was bred (FIG. 27).

(7) Results of Expression and Purification of ZntR Protein E. coli for expressing ZntR protein was cultured overnight at 37 ° C. in 5 mL of LB medium supplemented with Amp and Cm, and used as an inoculum. Two new 5 mL LB media supplemented with Amp and Cm were prepared, inoculated with each inoculum, and IPTG was added to one during the culture. Centrifugation was performed for 5 minutes under the conditions of 10,000 rpm and 4 ° C. from the obtained culture solution, and the cells were collected. The obtained bacterial cells were suspended in Tris buffer A, and the bacterial cells were crushed with an ultrasonic crusher. Thereafter, centrifugation was performed at 12,000 rpm and 4 ° C. for 10 minutes, and the supernatant was recovered. This was used as a crude extract of the ZntR protein, and the expression of the ZntR protein was confirmed by SDS-PAGE. As a result, a band seen as ZntR protein was confirmed only in the case where IPTG was added (the position of the arrow in FIG. 28). Therefore, the culture medium was scaled up to 250 mL for the purification of the ZntR protein, and cultured. did. Tris buffer A was added to the cells collected in the same manner as in the 5 mL culture scale, dissolved and disrupted by ultrasonic waves. Thereafter, the mixture was transferred to a centrifuge tube, centrifuged at 12,000 rpm and 4 ° C. for 10 minutes, and the supernatant was collected by decantation. This is defined as a ZntR protein crude extract.

  As the initial process of purification, ammonium sulfate precipitation was performed. Thereafter, gel filtration was continued for desalting, followed by affinity chromatography using a heparin column. At that time, about 5 mL of 40 fractions were collected. As a result of measuring the absorbance value of each fraction at 280 nm, several peaks of absorbance values were obtained. However, as a result of SDS-PAGE for the fractions forming these peaks, no band was confirmed at the position indicated by the arrow in FIG. It was speculated that the ZntR protein does not contain aromatic amino acids and therefore does not show light absorption at 280 nm. Therefore, 40 fractions were subjected to protein staining by the Bradford method, and the absorbance values at 595 nm were measured (FIG. 29). Since the peaks recognized up to fraction 5 were considered to be non-adsorbed fractions, fractions 9 to 15 forming peaks observed after fraction 5 were developed by SDS-PAGE.

  In fraction 10-13, a band considered to be a ZntR protein could be confirmed at the position of the arrow (FIG. 30, the position of the arrow). Thus, fractions 10-13 were combined and concentrated by ultrafiltration, protein quantification was performed by the Bradford method, and then gel filtration was performed for desalting. Furthermore, the ZntR protein was confirmed by SDS-PAGE (FIG. 31). As a result, since a band seen as a ZntR protein could be confirmed at the position indicated by the arrow, the subsequent experiment was performed using this ZntR protein partial purified solution.

(8) Results of EMSA using partially purified ZntR protein The result of quantification of partially purified ZntR protein was 0.53 mg / mL. EMSA was performed using probe DNA consisting of DNA labeled with ZntR protein and each fluorescent dye. Table 26 shows a list of each sample loaded on the electrophoresis gel. In the case of using FITC-labeled probe DNA, in the case of FITC labeling, blue excitation light is irradiated through an SCF515 filter (manufactured by ATTO), and in the case of TAMRA labeling, green excitation light is irradiated and an R-60 filter ( Images were taken through ATTO (FIG. 32). The band recognized in lane 1 is considered to be a single-stranded DNA, and the bands recognized in lanes 2 and 6 are considered to be double-stranded DNA bands. In the sample to which the ZntR protein partial purified solution was added, a band shift considered to be a band of the complex of the ZntR protein and the probe DNA was further observed, and the amount of the shifted band increased with the increase in the amount of the added protein. Was recognized. The probe DNA labeled with FITC or TAMRA was detectable as green or red fluorescence. From these results, it was revealed that the prepared recombinant ZntR protein and the probe DNA used specifically bound to form a complex.

  In EMSA using probe DNA labeled with FITC and TAMRA, a list of samples loaded on the gel for electrophoresis is shown in Table 27, and the experimental results are shown in FIG. The gel was photographed through an orange film irradiated with blue excitation light to excite FITC. Similar to the results of EMSA using a probe DNA labeled with one type of fluorescence, a sample shifted with a ZntR protein partially purified solution showed an upwardly shifted band that was considered to be a complex of ZntR protein and probe DNA. . In lane 1, green fluorescence was observed in the band of single-stranded DNA labeled with FITC, whereas red fluorescence was hardly confirmed in the single-stranded DNA labeled with TAMRA in lane 2. However, in the band derived from the probe DNA labeled with both FITC and TAMRA, pink fluorescence of an intermediate color between FITC green and TAMRA red was observed. From this result, it was confirmed that TAMRA was excited by green fluorescence emitted from FITC to emit red fluorescence, that is, FRET was generated from FITC to TAMRA on the probe DNA.

(9) Detection result of lead compound using ZntR protein partial purified solution and fluorescently labeled probe DNA As a result of measuring the fluorescence spectrum of the reaction mixture obtained by mixing the probe DNA double-labeled with FITC and TAMRA and the ZntR protein partially purified solution, Compared with the control to which the buffer was added by adding Pb or Zn, the fluorescence spectrum was only shifted upward. The same results were obtained with Na and Ca, which are metal ions, as with Pb and Zn (FIG. 34).

  The expected change in the fluorescence spectrum was that when Pb or Zn was present, the FITC 518 nm peak increased and the TAMRA 580 nm peak decreased. In addition, in Na, Ca, and control, it was expected that there was no change in the ratio between the 518 nm peak of FITC and the 580 nm peak of TAMRA. However, there was no change in the ratio of the FITC fluorescence peak (518 nm) to the TAMRA fluorescence peak (580 nm) when comparing the control with buffer and the addition of Pb or Zn.

  The reason why the ratio between the fluorescence peak of FITC and the fluorescence peak of TAMRA did not change in this test is that the distance between the fluorescent substances changes due to the change in the higher-order structure of the ZntR-promoter DNA complex when FRET occurs. Is a small point. In addition, there is a possibility that the amount of the fluorescently labeled probe DNA or ZntR protein added to the sample when performing the test was not appropriate as the addition amount for causing FRET.

(10) Breeding result of Escherichia coli strain for expressing ArsR protein In order to construct an As detection system via FRET, ArsR protein, which is a sensor protein for arsenic, was prepared as a recombinant protein. If a recombinant ArsR protein can be prepared, it is considered that the ArsR can be directly labeled with a fluorescent substance even if ArsR is not in the form of a fusion protein with GFP. Primers for arsR gene fragment amplification shown in Table 28 coli Ars R-S and E. coli. coilArsR-A was designed based on the DNA sequence data of Escherichia coli K12 (SEQ ID NO: 13 shows the sequence of E. coli ArsR-S, and SEQ ID NO: 14 shows the sequence of E. coli ArsR-A). The arsR gene was amplified by polymerase chain reaction (PCR) with Pfx50 ^™ DNA Polymerase using E. coli K12 strain genomic DNA as a template and primers E. coli ArsR-S and E. coli ArsR-A. After confirming amplification by electrophoresis, TaKaRa LA Taq ^™ with GC Buffer was added to the PCR reaction solution, and dATP was added to the 3 ′ end. This reaction solution was purified and ligated with a TA cloning vector and a pGEM-T vector to transform Escherichia coli JM109 strain (FIG. 35). PGEMarsR was extracted from the transformant, digested with XhoI and NdeI, and the inserted fragment was confirmed by electrophoresis. pGEmarsR and pET16b were treated with XhoI and NdeI, respectively, and for pGEMarsR, the band of the target arsR gene fragment (about 360 bp) was excised after electrophoresis and purified. In addition, pET16b was directly purified from the reaction solution and ligated with the arsR gene fragment. Escherichia coli JM109 strain was transformed with the ligation reaction solution. Confirmation of the insertion of the arsR gene into pET16b was performed by extracting a plasmid from the transformant, treating with XhoI and NdeI, and then confirming the band of the arsR gene fragment by electrophoresis. It was confirmed that there was no mutation in the cloned arsR gene by sequencing the arsR gene on pET16arsR and comparing it with the E. coli K12 strain DNA sequence data in the Gen Bank database. However, since the ArsR protein expressed from pET16arsR has a His tag and may bind to a heavy metal via the His tag, the arsR gene fragment was religated to the pET3a vector without the His tag. It was to be. The pET16arsR and pET3a vectors were treated with BamHI and NdeI, respectively. For pET16arsR, the band of the desired arsR gene fragment was excised after electrophoresis and purified. The arsR gene fragment was ligated with the pET3a vector to prepare pET3arsR. Sequencing was performed in the same manner as described above, and it was confirmed that there was no mutation in the arsR gene on pET3arsR by comparing with Gen Bank's Escherichia coli K12 strain DNA sequence data. Next, the Escherichia coli BL21 (DE3) pLysS for protein expression was transformed with the plasmid solution of pET3arsR, and the Escherichia coli strain for expressing ArsR protein was bred (FIG. 35).

(11) Expression and confirmation of recombinant ArsR protein An ArsR protein crude extract was obtained by culturing an Escherichia coli strain for expression of ArsR protein after culturing. This ArsR protein crude extract was developed by SDS-PAGE to confirm the expression of ArsR protein. However, no band could be confirmed at the position where the band of ArsR protein was predicted (about 13 kDa) regardless of the presence or absence of IPTG addition. In the crude protein extract at the time of IPTG addition, since bands were concentrated at the top of the gel, there was a possibility that ArsR protein and DNA were bound. Therefore, the protein crude extract was treated with DNase I for the purpose of removing DNA bound to the protein, and then the ArsR protein band was confirmed again by SDS-PAGE. However, no difference was observed in the band at the position predicted by the presence or absence of IPTG addition. Although the cause has not been specified, a recombinant ArsR protein has not been prepared. Therefore, it was decided to fluorescently label ArsR by preparing it in the form of a fusion protein with GFP.

(12) Results of breeding of Escherichia coli strain for expression of ArsR-GFP fusion protein ArsR gene amplification primers Ec-arsR-pAcGFP-S (SEQ ID NO: 15) and Ec-arsR shown in Table 29 for cloning of the arsR gene fragment -pAcGFP-A (SEQ ID NO: 16) was designed based on the DNA sequence data of Escherichia coli K12 strain. Each primer was provided with a restriction enzyme site required for cloning. First, the arsR gene fragment was amplified by PCR using primers Ec-arsR-pAcGFP-S and Ec-arsR-pAcGFP-A using the genomic DNA of Escherichia coli K12 strain as a template (FIG. 36). After confirming amplification by electrophoresis, the arsR gene fragment and the pAcGFP1 vector were treated with HindIII and PstI, respectively, and for pAcGFP1, the band at the target vector site (about 3.3 kb) was excised and purified after electrophoresis. Moreover, the reaction liquid was purified as it was for the arsR gene fragment. Both DNA fragments were ligated, and Escherichia coli JM109 was transformed with the obtained pAcGFParsR. The insertion of the arsR gene was confirmed by extracting pAcGFParsR from the transformant, digesting with HindIII and PstI, and then confirming the band of the arsR gene fragment (about 360 bp) by agarose gel electrophoresis. A sequence on pAcGFPParsR was performed, and it was confirmed that there was no mutation in the arsR gene on pAcGFPParsR by comparison with the DNA sequence data of arsR of E. coli K12 strain of Gen Bank.

(13) Expression and Confirmation of ArsR-GFP Fusion Protein An Escherichia coli strain for expressing ArsR-GFP fusion protein was cultured and disrupted to obtain an ArsR-GFP fusion protein crude extract. This ArsR-GFP fusion protein crude extract was developed by SDS-PAGE to confirm the expression of the ArsR-GFP fusion protein. As a result, a band was confirmed at the predicted position (about 47 kDa) of the ArsR-GFP fusion protein (position of the arrow in FIG. 37). However, since the expression level was low, the target protein was partially purified by affinity chromatography to increase the ratio to the contaminating protein.

(14) Purification results of ArsR-GFP fusion protein Ammonium sulfate precipitation was performed on the ArsR-GFP fusion protein crude extract, redissolved in the buffer, and then desalted by gel filtration. Thereafter, fluorescence was measured (520 nm) of the _{A 280} and GFP of recovered forty fraction was purified by affinity chromatography. As a result, it observed peak of _{A 280} and fluorescence values around a fraction 19 and 20 (FIG. 38), ArsR-GFP fusion protein was found to be mainly present in these fractions. When the protein was confirmed by SDS-PAGE for fractions 19 and 20, a band considered to be an ArsR-GFP fusion protein was confirmed (FIG. 39, position of arrow).

However, since contaminating proteins were still recognized in addition to the target protein, ion exchange chromatography was performed using these fractions in order to further increase the degree of purification. Thereafter, A ₂₈₀ and fluorescence intensity (420 nm) of the collected 40 fractions were measured. As a result, a peak of A ₂₈₀ was recognized centering on fractions 19 to 21, and fluorescence values were mainly high in fractions 20 and 21 (FIG. 40). It was revealed that ArsR-GFP fusion protein is mainly present in fractions 20 and 21. When fractions 20 and 21 were separated by SDS-PAGE, a band considered to be an ArsR-GFP fusion protein was confirmed (FIG. 41, position of arrow). By performing purification by ion exchange chromatography, contaminating proteins other than the ArsR-GFP fusion protein could be largely removed.

(15) As detection test using ArsR-GFP fusion protein and fluorescently labeled probe DNA Whether or not the presence of the arsenic compound (As) changes the fluorescence spectrum via FRET based on the principle shown in FIG. Went. FIG. 42 shows the results of mixing the partially purified solution of ArsR-GFP fusion protein and ParsR-350 labeled with TAMRA and measuring the fluorescence spectrum at excitation light of 350 nm and 360 nm in the presence and absence of As. In any excitation light, the fluorescence intensity of TAMRA near 580 nm was slightly decreased when added than when As was not added. Further, in the fluorescence peak of GFP near 510 nm, a slight increase in the peak was observed at the time of addition than when no As was added. This tendency is consistent with the change in the fluorescence spectrum predicted from the detection principle shown in FIG. That is, when As is not added, the distance between TAMRA and GFP is shortened by the formation of a complex of protein and DNA, and the fluorescence of GFP is easily absorbed as TAMRA excitation light. As a result, the fluorescence of TAMRA increases. It is considered that the fluorescence of GFP increased as a result of the dissociation of DNA and the distance between TAMRA and GFP and the proportion of GFP fluorescence absorbed by TAMRA decreased. However, since the remarkable change by addition of As was not recognized in the ratio of the fluorescence intensity of TAMRA and GFP, the length of the DNA strand was shortened from 350 bp to 50 bp using ParsR-50 or R773-50 probe DNA. A detection test was conducted. As a result, in any excitation light and probe DNA, the same spectral change was observed when ParsR-350 probe DNA was used by addition of As (FIGS. 43 and 44). In addition, in the fluorescence of TAMRA near 580 nm, a decrease was observed when ParsR-350 probe DNA was used by adding As. However, in any of the probe DNAs, the GFP fluorescence intensity did not increase with the addition of As. In comparison between ParsR-50 and R773-50 probe DNA, the amount of decrease in TAMRA fluorescence was greater when ParsR-50 probe DNA was used by adding As.

  As a result of the arsenic detection test using three different probe DNAs, the probe DNA chain length was set to 50 bp, and the base sequence of the arsenic-responsive promoter on the genome was selected. It has become clear that this causes a change. Although the chain length and the base sequence of the probe DNA were changed, the expected fluorescence spectrum change via FRET could not be brought about.

(16) Summary The results of Pb or As detection tests using the two prepared recombinant proteins, ZntR or ArsR-GFP, are summarized below.
In the test using the probe DNA and the ZntR protein in which the promoter DNA was double-labeled with FITC and TAMRA, no change was observed in the ratio of the fluorescence intensity of FITC and TAMRA with the addition of Pb. From the analysis result by the gel shift method, it was confirmed that the prepared ZntR protein and the probe DNA form a ZntR-promoter DNA complex. Therefore, it is considered that the higher-order structural change of the formed complex due to the addition of Pb was too small to cause the change of energy transfer in FRET. It was difficult to externally present changes in the higher-order structure of the ZntR-promoter DNA complex via FRET.

  On the other hand, it was difficult to express wild-type ArsR protein in an E. coli strain for As detection. For this reason, when expressed as an ArsR-GFP fusion protein, it became possible to fluorescently modify the ArsR protein with GFP. It was confirmed whether or not dissociation of DNA molecules from the protein-DNA complex caused by the addition of As can be externally presented as a change in fluorescence spectrum by adding fluorescence modification with TAMRA to the promoter DNA. As a result, a slight change was observed in the ratio of the fluorescence intensity of GFP and TAMRA with the addition of As. From the test results using three different probe DNAs, it became clear that the fluctuation range of the fluorescence intensity due to the addition of As slightly changed due to the difference in the chain length and base sequence of the probe DNA. The probe DNA used in the test in which the fluorescence intensity of TAMRA changed the most was ParsR-50 in which TAMRA was modified to arsenic-responsive promoter DNA 50 bp on the strain genomic DNA.

  The cause of the weak change in fluorescence intensity in the As detection test is that both interacting protein and DNA molecules were in solution at the time of the test. Since the molecules move freely in the solution, it is possible that background FRET has occurred not a little, regardless of the state of binding / dissociation of the molecules. Therefore, in order to make the change in fluorescence intensity more prominent, there is a measure of immobilizing probe DNA on the substrate surface in a modified form. If the FRET due to arsenic addition is remarkably reduced by immobilizing the probe DNA, it can be applied to an assay system using a microplate, and a future high-throughput As detection system is expected. However, in the present method in which the probe DNA was not immobilized, a practical change in FRET, that is, a change in fluorescence spectrum did not occur.

  According to the present invention, it is possible to detect and measure an analyte in a test sample simply and quickly using a sensor protein derived from a microorganism.

Claims (15)

A method for detecting or quantifying an analyte in a test sample in an aqueous system, comprising the following steps (A) and (B):
(A) A sensor protein that specifically binds to the analyte, and a nucleic acid immobilized on a support and containing a sequence specifically recognized by the sensor protein, in the presence of a test sample. A step of reacting (B) a step of detecting or measuring a sensor protein bound to the immobilized nucleic acid; The method according to claim 1, wherein the sensor protein is labeled with a detectable marker. The method according to claim 1, wherein the sensor protein is a fusion protein with a detectable marker protein. A method for detecting or quantifying an analyte in a test sample in an aqueous system, comprising the following steps (A) and (B):
(A) A sensor protein that specifically binds to the analyte immobilized on a support and a nucleic acid containing a sequence specifically recognized by the sensor protein are reacted in the presence of a test sample. (B) detecting or measuring the nucleic acid bound to the immobilized sensor protein 5. The method of claim 4, wherein the nucleic acid is labeled with a detectable marker. 6. The method according to claim 1, wherein the binding between the sensor protein and the nucleic acid is inhibited by the analyte. The method according to claim 1, wherein the sensor protein is a protein encoded by a metal responsive operon. 8. The method according to claim 7, wherein the protein encoded by the metal responsive operon is ArsR protein or CadC protein. The method according to claim 1, wherein the analyte is a heavy metal compound. 10. The method of claim 9, wherein the heavy metal compound is selected from arsenic (As) compounds, cadmium (Cd) compounds, and lead (Pb) compounds. The method according to claim 10, wherein a pentavalent arsenic (As (V)) compound is reduced in advance and converted to a trivalent arsenic (As (III)) compound. The reaction between a sensor protein and a nucleic acid containing a sequence specifically recognized by the sensor protein is carried out in a phosphate buffer solution (pH 7.4) of 50 mM or more. The method described. The method according to any one of claims 9 to 11, wherein the reaction between the sensor protein and a nucleic acid containing a sequence specifically recognized by the sensor protein is carried out in a 40 mM or higher sodium chloride solution. In a test sample, comprising: a sensor protein that specifically binds to an analyte; and a nucleic acid immobilized on a support that includes a sequence that is specifically recognized by the sensor protein. Analyte detection or quantification kit. An analysis in a test sample, comprising: a sensor protein that specifically binds to an analyte immobilized on a support; and a nucleic acid containing a sequence that is specifically recognized by the sensor protein. Detection or quantification kit for objects.